A prospective, multicenter, randomized, parallel-group controlled trial to compare conservative versus surgical treatment of foot drop in peroneal nerve entrapment.
- Conditions
- compression of the peroneal nerveperoneal neuropathy1003460610009720
- Registration Number
- NL-OMON54026
- Lead Sponsor
- niversitaire ziekenhuizen Leuven
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
1. Written informed consent to participate in the study must be obtained from
the subject or proxy / legal representative prior to initiation of any
study-mandated procedure
2. EDX-documented peroneal nerve entrapment with persisting (10 ± 4 weeks) foot
drop (MRC-score <= 3)
3. Imaging (ultrasound/MRI) performed to exclude a compressive mass
4. Age >= 18 years
1. Subjects with posttraumatic or iatrogenic peroneal nerve injury
2. Subjects with peroneal neuropathy due to a compressive mass (e.g. cyst,
tumour)
3. Peroneal nerve entrapment at other sites than the fibular head
4. Bilateral peroneal nerve entrapment
5. Patients with mental or physical problems that incapacitate them to
participate in a physiotherapy program
6. Psychiatric illness
7. Pregnancy
8. Planned (e)migration within 1 year after randomization to another country
9. Subjects with previous foot drop
10. Permanently bedridden subjects
11. Subjects with neurological or musculoskeletal history which could impact
foot drop assessment and/or gait analysis (e.g. polyneuropathy, hereditary
neuropathy with pressure palsies, critical illness polyneuropathy, previous
stroke, ankle surgery, ankle sprain, *).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary research question of the trial is to assess whether foot drop,<br /><br>caused by peroneal nerve entrapment in adult patients* recovers better within 9<br /><br>months after decompressive surgery compared to prolonged standard conservative<br /><br>treatment.<br /><br><br /><br>The primary endpoint is the difference in distance covered in meters during the<br /><br>six-minute walk test (6MWD) between baseline and 9 months after randomization. </p><br>
- Secondary Outcome Measures
Name Time Method